A genetic test for breast cancer mutations linked to Ashkenazi Jews misses the mutations about 12 percent of the time, according to a new study. The test searches for the BRCA-1 and BRCA-2 mutations, which are carried by 2 percent of Ashkenazi Jews and have been linked to both breast and ovarian cancers, according to the Human Genome Project in Washington.
Help ensure Jewish news remains accessible to all. Your donation to the Jewish Telegraphic Agency powers the trusted journalism that has connected Jewish communities worldwide for more than 100 years. With your help, JTA can continue to deliver vital news and insights. Donate today.
The Archive of the Jewish Telegraphic Agency includes articles published from 1923 to 2008. Archive stories reflect the journalistic standards and practices of the time they were published.
